22 articles for CA Janson
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
40
Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domain.

Hoffmann-La Roche
23
Benzazepinones and benzoxazepinones as antagonists of inhibitor of apoptosis proteins (IAPs) selective for the second baculovirus IAP repeat (BIR2) domain.

Hoffmann-La Roche
1
Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsites.

Smithkline Beecham Pharmaceuticals
8
Structure-based design of cathepsin K inhibitors containing a benzyloxy-substituted benzoyl peptidomimetic.

Smithkline Beecham Pharmaceuticals
11
Identification of an Adamantyl Azaquinolone JNK Selective Inhibitor.

TBA
15
Azepanone-based inhibitors of human and rat cathepsin K.

Glaxosmithkline
13
Conformationally constrained 1,3-diamino ketones: a series of potent inhibitors of the cysteine protease cathepsin K.

Smithkline Beecham Pharmaceuticals
15
Protein structure-based design, synthesis, and biological evaluation of 5-thia-2,6-diamino-4(3H)-oxopyrimidines: potent inhibitors of glycinamide ribonucleotide transformylase with potent cell growth inhibition.

Agouron Pharmaceuticals
14
Structure-based design of substituted diphenyl sulfones and sulfoxides as lipophilic inhibitors of thymidylate synthase.

Agouron Pharmaceuticals
24
Design of thymidylate synthase inhibitors using protein crystal structures: the synthesis and biological evaluation of a novel class of 5-substituted quinazolinones.

Agouron Pharmaceuticals
15
Synthesis and biological evaluation of novel 2,6-diaminobenz[cd]indole inhibitors of thymidylate synthase using the protein structure as a guide.

Agouron Pharmaceuticals
14
Design of enzyme inhibitors using iterative protein crystallographic analysis.

Agouron Pharmaceuticals
14
Design and synthesis of novel 6,7-imidazotetrahydroquinoline inhibitors of thymidylate synthase using iterative protein crystal structure analysis.

Agouron Pharmaceuticals
41
Piperidine substituted tricyclic pyrazolo[1,5-a]pyrimidine derivatives with inhibitory activity on the replication of the respiratory syncytial virus (RSV)

Janssen Ireland
231
Substituted tricyclic compounds as FGFR inhibitors

Incyte
43
Substituted tetrahydrocarbazole and carbazole carboxamide compounds

Bristol-Myers Squibb
48
Aniline derivative, pharmaceutical composition containing same, and use thereof

Kissei Pharmaceutical
16
1-Acyl-1H-[1,2,4]triazole-3,5-diamine analogues as novel and potent anticancer cyclin-dependent kinase inhibitors: synthesis and evaluation of biological activities.

Johnson & Johnson Pharmaceutical
46
Bis(1H-2-indolyl)methanones as a novel class of inhibitors of the platelet-derived growth factor receptor kinase.

University of Regensburg
70
2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1.

Glaxosmithkline
35
Nonpeptide cyclic cyanoguanidines as HIV-1 protease inhibitors: synthesis, structure-activity relationships, and X-ray crystal structure studies.

Dupont Pharmaceuticals
9
Stereoisomers of cyclic urea HIV-1 protease inhibitors: synthesis and binding affinities.

Dupont Pharmaceuticals